Our commitment to making a meaningful difference to patient health is founded on innovative science. In a rapidly changing world, we are transforming the way – and where – we work to make the most of the opportunities that new sciences and technologies bring to the search for new medicines.
Our new UK-based global research centre and corporate HQ will be located at the Cambridge Biomedical Campus, putting us at the heart of a world-renowned bioscience hub that is home to some of the world’s best scientists, clinicians and research institutions.
Hear more from Dr Mene Pangalos, our head of Innovative Medicines and Early Development.
To strengthen the potential for successful innovation, we combine resources and skills with others in the pursuit of new advances in healthcare. One of our latest collaborations is with Cancer Research UK and the University of Manchester. Work will focus on developing new drugs that target a key protein involved in DNA damage response.